2025.q1
274 Titles |
MAIN KEYWORDS |
Africa, Care, Children, Drug, Health, Impact, Living, Patients, People, Prevention, Programmes, Research, Risk, Therapy, Treatment, WHO
Drag keyword — Find in page
— ZA 42892 — Prevalence and factors associated with knowledge of HIV Self-Test kit and ...
— ZA 42893 — Viral suppression in the context of SARS-CoV-2 among children infected with HIV-1 ...
— ZA 42894 — Foreign aid cuts could lead to 10 million new HIV cases by 2030, research shows
— ZA 42895 — ANAC Series Addresses HIV Risk and Barriers in Transgender Health Care
— ZA 42896 — 10 syringe sharing drug users found HIV positive at Valanchery
— ZA 42897 — Cuts to the CDC's Division of HIV Prevention Will Lead to Dramatic Rise in Infections ...
— ZA 42898 — Up to 11 mln new HIV infections expected after cut
— ZA 42891 — Keratin-72 restricts HIV-1 infection in resting CD4+ T cells by sequestering capsids in ...
— ZA 42899 — HIV research grants being put on hold by National Institutes of Health
— ZA 42902 — First HIV cure clinical trial in Africa shows promise in women
— ZA 42900 — HIV research funding cuts threaten global health goals
— ZA 42901 — HIV soars after deadly war in Ethiopia's Tigray, with US aid cuts not helping
— ZA 42903 — UNAIDS welcomes Nigeria to the Global Partnership for Action to Eliminate all Forms of HIV ...
— ZA 42904 — PEPFAR Reauthorisation Expires With No Clear Path For Renewed Aid
— ZA 42905 — How Ukrainians are fighting to keep HIV Treatment going Amid War
— ZA 42910 — Risk of 2,000 new HIV infections a day after US aid freeze, UN says
— ZA 42906 — TB And Chronic Illness: The Overlooked Impact Of HIV And Diabetes
— ZA 42912 — Despite progress, HIV stigma and discrimination continue to bubble beneath the surface in Thailand
— ZA 42911 — UNAIDS chief warns of 'real surge' in deaths unless US restores funding
— ZA 42909 — Youths' 'Yolo' mentality linked to risky behaviour, contributing to rising HIV infection rate
— ZA 42907 — Lancet Commission IDs Trends With Extended Data on Global Access to Palliative Care
— ZA 42908 — Broadly Neutralizing Antibodies Show Promise for Long-Acting HIV Treatment
— ZA 42913 — The silent epidemic: Mpox's resurgence in Africa calls for urgent global health action
— ZA 42914 — 'Some won't survive': US cuts threaten S.Africa's young HIV patients
— ZA 42915 — Twice Daily TB Therapies Show Similar Neuropsychiatric Outcomes in Patients with HIV
— ZA 42916 — Ricky Martin, Martha Stewart, and $3.8M Raised: Inside amfAR's Palm Beach Gala
— ZA 42917 — Uganda's Health Ministry Refutes Reports of ARV Drug Shortages
— ZA 42918 — WHO announces the development of updated guidance on HIV service delivery
— ZA 42919 — Expanded Use of Long-Acting Injectables for HIV and HIV Prevention
— ZA 42920 — No Shortages of HIV Drugs in Nigeria
— ZA 42921 — WHO Unveils Updated HIV Service Delivery Guidance
— ZA 42925 — Study shows significant progress in HIV treatment initiation in the Asia-Pacific region
— ZA 42922 — Electronic cigarettes may pose lower cardiovascular risks for people with HIV
— ZA 42923 — Impact of US funding cuts on HIV programmes in Latin America and the Caribbean
— ZA 42924 — Impact of US funding cuts on HIV programmes in Vietnam
— ZA 42926 — Impact of US funding cuts on HIV programmes in Rwanda
— ZA 42927 — A novel fractal fractional mathematical model for HIV/AIDS transmission stability and ...
— ZA 42928 — HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5
— ZA 42929 — Trends and Disparities Among the US Residents in HIV Mortality
— ZA 42931 — New Method Marks Immune Cells Where HIV Lies Dormant
— ZA 42936 — People living with HIV are under attack
— ZA 42935 — Estimating HIV incidence in Türkiye: results from two mathematical models
— ZA 42934 — HIV acquisition in women with good adherence to TAF/FTC PrEP is rare
— ZA 42932 — New long-acting HIV drugs show promising early results
— ZA 42930 — George House Trust celebrates 40 years of helping people with HIV
— ZA 42933 — 'Promising results' for Durban HIV cure trial
— ZA 42939 — Cuts to USAID-funded research another blow to global HIV response
— ZA 42944 — US aid cuts could wipe out 29000 health jobs
— ZA 42943 — MSD to push for approval of HIV combo after Phase III success
— ZA 42942 — The role of digital tools in enhancing antiretroviral therapy adherence among adolescents ...
— ZA 42940 — HIV self-testing is easy, effective — and underutilized
— ZA 42938 — A Game-Changer for HIV Treatment?
— ZA 42937 — Antiretrovirals Alone Don't Delay Language in Children
— ZA 42941 — Scientists develop yearly HIV injection: How it could help millions
— ZA 42945 — Africa: New Delivery, New Hope - Dolutegravir Oral Film Study Changes in HIV Prevention ...
— ZA 42946 — Two more people with HIV may be cured after stem cell transplants
— ZA 42947 — HIV pioneer David Polson farewelled at state funeral in Sydney
— ZA 42948 — Africa's defining moment: the time to lead the HIV response is now
— ZA 42949 — HIV Treatment Remains Free in Government Facilities
— ZA 42950 — Impact of US funding freeze on HIV programmes in Peru
— ZA 42951 — Virological Outcomes of Dolutegravir/Lamivudine in HIV Treatment
— ZA 42956 — US biochemist researching treatment of HIV and coronaviruses wins Israel's Wolf Prize
— ZA 42958 — Immunocore T-cell engager clears safety hurdle, reduces HIV reservoir in some patients
— ZA 42959 — Camp Dreamcatcher has served thousands of children living with HIV
— ZA 42957 — Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIV
— ZA 42954 — Loss of US assistance hampering Tajikistan's efforts to contain HIV
— ZA 42952 — HIV And STIs Are Rising Globally, Especially In Dallas
— ZA 42953 — Assessing HIV-1 subtype C infection dynamics, therapeutic responses and reservoir ...
— ZA 42955 — San Francisco low-income housing co-op for people with HIV, AIDS fights to stay open
— ZA 42964 — Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo
— ZA 42960 — Cote d'Ivoire: care for HIV/AIDS fully guaranteed despite suspension of U.S. aid
— ZA 42967 — HIV Viral Suppression With Use of Long-Acting Antiretroviral Therapy in People
— ZA 42965 — LGBTI in Cameroon: U.S. ends anti-HIV programs, leaving only homophobic clinics
— ZA 42963 — Nearly half of women in Africa will be obese or overweight by 2030
— ZA 42962 — Protecting Key Populations From Abrupt Disruptions to Essential HIV Services
— ZA 42961 — Our HIV response will collapse without US funding - unless we act urgently
— ZA 42966 — Long-acting injectable HIV therapy offers hope for those unable to take pills
— ZA 42968 — Impact of US funding freeze on HIV/AIDS and TB
— ZA 42969 — Shock as Mpox mutates AGAIN - new variant is highly transmissible, concerned experts warn
— ZA 42970 — I've Seen Firsthand How PEPFAR Works
— ZA 42971 — Doctors vastly under-report deaths from HIV, MRC report finds
— ZA 42973 — Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 .
— ZA 42974 — Pepfar funding to fight HIV/Aids has saved 26 million lives since 2003: how cutting it will hurt Africa
— ZA 42972 — USAID funding cuts end vital HIV programme for SA orphans
— ZA 42975 — US grant cuts could affect two million worldwide, disrupt HIV aid in Kenya
— ZA 42982 — An overview of HIV history and its Queer criminalization
— ZA 42976 — Four ways to help beat health inequities in the face of USAID cuts
— ZA 42977 — Gilead Sciences sets aside $200 million to resolve HIV drug probe
— ZA 42978 — Accessible HIV science is vital in an age of disinformation
— ZA 42979 — From research to reality: how studying innovative HIV medicines in the “real world” helps ...
— ZA 42980 — US Ends Funding for Thousands of Global Health Programs
— ZA 42981 — USAID funding cuts end vital HIV programme for orphans
— ZA 42990 — Halt In US HIV Funds Could Cost S.Africa 500000 Lives Over 10 Years
— ZA 42989 — Country's ARVs stock can only last for six months
— ZA 42988 — GLAAD Celebrates Black Queer and Trans Women, HIV Advocacy, and the Power of ..
— ZA 42987 — Nigerian drug regulator discovers USAID-funded medications in local markets
— ZA 42986 — Unraveling the Complexity of Non-typhoidal Salmonella Genitourinary Infection in HIV
— ZA 42985 — FG launches campaign to eliminate HIV, Syphilis, Tuberclosis
— ZA 42983 — WHO Boosts Data Quality for Stronger HIV Programs
— ZA 42984 — Mizoram Faces HIV Crisis: Over 32000 Infected, Making It The State With Highest HIV Rate In India
— ZA 42991 — South Africa ramps up efforts to get 1.1 million people back on HIV treatment
— ZA 42994 — Honduras' HIV response at risk due to U.S. freeze of foreign assistance
— ZA 42992 — Study provides support for WHO guidelines for treating pregnant women with HIV
— ZA 42993 — USAID cuts mean uncertain future for Kenyan children with HIV
— ZA 42995 — Gilead's lenacapavir applications for HIV gain EMA validation
— ZA 42996 — 'HIV in soda' hoax scares Philippine social media users
— ZA 42997 — Clinical characteristics and treatment outcomes of opportunistic infections in advanced HIV ...
— ZA 42998 — US funding freeze could mean HIV treatment delays for thousands in Ukraine
— ZA 43001 — Actinomyces israelii Brain Abscess With Advanced HIV Disease
— ZA 43006 — Evaluating the level of knowledge of HIV prevention methods and associated
— ZA 43005 — An upcoming Supreme Court case could make PrEP less affordable—does it have to?
— ZA 43004 — Cardiovascular Risk Calculators Fail Some Patients With HIV
— ZA 43002 — Fill the Gap Left by USAid Freeze
— ZA 43000 — Status of HIV Programmes in Indonesia
— ZA 42999 — Relying on foreign funding for HIV fight is risky
— ZA 43003 — Almost two-thirds of people with HIV in Ireland feel 'stigmatized' because of their condition
— ZA 43009 — Mpox Transmission Rising
— ZA 43013 — The Role of Transparency in Healthcare and HIV/AIDS Fundraising
— ZA 43012 — Urgent and accelerated HIV service delivery with equity and rights is critical to end AIDS
— ZA 43014 — Identifying barriers and facilitators to psychosocial care for people living with HIV in Ireland
— ZA 43008 — New Therapy May Effectively Control HIV In Uganda
— ZA 43007 — Malaysia : 64% of HIV cases in 2024 involved homosexuals, bisexuals
— ZA 43011 — HIV patients fear stigma as govt integrates services
— ZA 43010 — Knowledge, attitude, and practice of HIV/AIDS transmission and prevention among barbing ...
— ZA 43015 — Triple Antibody Cocktail Delays HIV Rebound After Antiretrovirals
— ZA 43016 — Scientists develop new natural killer cell strategy to target HIV
— ZA 43018 — Non-AUG HIV-1 uORF translation elicits specific T cell immune response and regulates viral ...
— ZA 43019 — USAid-funded HIV organisations in SA struggle to return to work
— ZA 43017 — Post-Sex Doxycycline Slashes STI Risk in HIV PrEP Users
— ZA 43020 — How the health department will deal with Pepfar's near collapse
— ZA 43026 — Identification of pathogens in HIV-infected patients using metagenomic
— ZA 43021 — Nigeria acts on HIV/AIDS funding as U.S .aid halts
— ZA 43022 — Former Wales captain Gareth Thomas says his husband is shunned over rugby star's HIV status
— ZA 43023 — America's engagement with Africa mustn't be allowed to wither
— ZA 43024 — This is what happens to the body when HIV drugs are stopped for millions of people
— ZA 43025 — Health officials urge regular testing after Arkansas sees rise in HIV, syphilis cases
— ZA 43027 — How will the Mnangagwa regime afford ARVs when they can't even provide paracetamol?
— ZA 43029 — A crisis unfolding: hard-won progress in Ethiopia's HIV response at risk
— ZA 43030 — UNAIDS urges countries to invest in HIV prevention as key to ending AIDS
— ZA 43031 — Immune-mediated strategies to solving the HIV reservoir problem | Nature Reviews Immunology
— ZA 43032 — Cuts to PEPFAR Spell Detrimental HIV Outcomes in South Africa
— ZA 43033 — ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize ...
— ZA 43034 — What happens if HIV drugs are stopped for millions of people
— ZA 43035 — HIV Protein Could Help Make “Off-the-Shelf” CAR T Cells a Reality
— ZA 43028 — Preventing HIV in women in Africa
— ZA 43036 — HIV campaigner and Qtopia founder David Polson dies aged 70
— ZA 43037 — Govt integrates HIV services as over 1000 lose jobs
— ZA 43044 — Why govt is closing all HIV clinics
— ZA 43045 — Scottish Medicines Consortium approves the uses of long-lasting, injectable PrEP
— ZA 43043 — UK's Starmer urges world leaders to test for HIV
— ZA 43042 — Outcomes of switching from protease inhibitor-based antiretroviral therapy to bictegravir ...
— ZA 43040 — Treatment of HIV/AIDS in Haiti hit by U.S. aid halt despite Rubio's waivers
— ZA 43038 — Mozambique: US aid halt threatens health care especially HIV/AIDS
— ZA 43039 — Risk factors for mother-to-child transmission of HIV infection in Ghana
— ZA 43041 — US aid funding cuts put HIV prevention at risk, warns UNAIDS
— ZA 43051 — Report Shows How Much US Has Sent to Nigeria as Foreign Aid Over the Last 10 Years ...
— ZA 43046 — Bangladesh group condemns anti-gay discrimination at Islamic University
— ZA 43052 — Ethiopia: Responding to Impact of USAID Pause
— ZA 43050 — Beyond rallies and rhetoric, what can be done to block deadly foreign aid cuts?
— ZA 43049 — US aid freeze to disrupt HIV prevention efforts in PH, says group
— ZA 43048 — Experts call for renewed public education to address rising HIV rates
— ZA 43047 — Budgeting for HIV/Aids drugs locally is plausible
— ZA 43053 — What's up with the Philippines' 534% increase in HIV cases?
— ZA 43054 — Factors contributing to retention in care and treatment adherence amon
— ZA 43055 — South Africa's HIV clinics scramble over US aid freeze
— ZA 43056 — Researchers Establish Dormice Model To Study Monkeypox Virus Infection
— ZA 43057 — 'Unreliable partner': S.Africa's HIV clinics scramble over US aid freeze
— ZA 43063 — What Is hMPV, and Could It Be the Next Pandemic?
— ZA 43059 — HIV cases in Malaysia: 90% men, largest age group in their 20s
— ZA 43065 — SCDPH offers free STD/HIV testing to promote awareness among Black communities
— ZA 43064 — Multiple health agency websites on HIV, contraception taken down to comply with executive orders
— ZA 43058 — Alarm bells ring: Rise in advanced HIV cases in Tanzania
— ZA 43060 — SA's HIV/Aids NPOs await clarity on partial waiver to US aid freeze
— ZA 43061 — Initiative to improve sexual health
— ZA 43062 — Viral load suppression rate of third-line antiretroviral therapy and its association with gender ...
— ZA 43066 — Chaos for Millions in HIV/AIDS Treatment Program in Africa
— ZA 43067 — Dual HIV/syphilis rapid test aims to lessen stigma, reach underserved communities
— ZA 43068 — Decoding HIV-associated neurocognitive disorders: a new perspective from multimodal
— ZA 43069 — Lifesaving HIV/AIDS program's future uncertain amid stop-and-start foreign aid pause
— ZA 43070 — HIV-1 resistance mutations and genetic diversity among children failing antiretroviral ...
— ZA 43071 — My friend just tested positive for HIV: What can I do to support them?
— ZA 43072 — Tanzania's path to independence following US decision on ARVs
— ZA 43073 — Ghana to lose over $138m as US aid withdrawal hits health and HIV/AIDS programs
— ZA 43076 — WHO urges US to maintain support for HIV treatment programmes
— ZA 43077 — Binge Eating May Be Contributing to Weight Gain in People With HIV
— ZA 43074 — Mental health challenges and perceptions of stigma among youth living with HIV in Tanzania
— ZA 43075 — Pause to AIDS funding leaves health experts scrambling
— ZA 43079 — Large-scale HIV trial set to build capacity in clinical trial management in Africa
— ZA 43080 — PEPFAR freeze risks HIV treatment for millions in South Africa and around the world
— ZA 43081 — What US 'stop work order' means for Uganda, HIV care programmes
— ZA 43078 — The primary mechanism for highly potent inhibition of HIV-1 maturation by lenacapavir
— ZA 43083 — Laurus Labs says 'no significant impact' on business from AIDS funding freeze, WHO withdrawal
— ZA 43089 — Blushwood Compound Offers Hope for HIV Cure Through "Kick and Kill" Strategy
— ZA 43088 — What a U.S. Exit From the World Health Organization Means for Global Health
— ZA 43087 — Marco Rubio cuts off foreign aid for millions of people's HIV medications
— ZA 43086 — Global health spending makes America safe, strong, and prosperous
— ZA 43084 — How the US came to fund global treatment for HIV AIDS
— ZA 43082 — High Prevalence of Posttraumatic Stress Disorder Symptoms Found in Well-Treated People ...
— ZA 43085 — Cancer-fighting compound shows immense potential to eradicate HIV
— ZA 43095 — Aids/TB research in danger after US regime change
— ZA 43094 — How can we end childhood sexual violence?
— ZA 43096 — Predictors associated with time to default for HIV/AIDS patients under HAART at Debre
— ZA 43092 — 55% of new HIV cases caused by injecting drug use
— ZA 43091 — How Broadly Neutralizing Antibodies Are Driving Next-Gen Vaccines
— ZA 43090 — Baby boys from KZN hold hope for HIV cure
— ZA 43093 — Recent Meta-Analysis Reveals Limited HIV Control After Treatment Interruptions
— ZA 43097 — New Study Finds Social Programs Could Reduce the Spread of HIV by 29%
— ZA 43098 — Effects of HIV exposure on anemia and vitamin D nutritional status in children aged 6–24 months
— ZA 43099 — Who needs PrEP for HIV Prevention?
— ZA 43100 — Have we cured AIDS? The incredible progress we've made against HIV, explained
— ZA 43102 — Irish HIV activist and former priest Bernárd Lynch receives Freedom of the City of London
— ZA 43108 — Mpox: Nigeria records 1484 suspected cases amid regional spread
— ZA 43107 — Details emerge on Shs300b expired ARVs, test kits
— ZA 43106 — How South Africa's spaza shops shifted from food frights to condom conundrums
— ZA 43105 — Sharp decline in HIV and AIDS in India
— ZA 43103 — Mpox surge: Uganda must act now
— ZA 43101 — Global study highlights underestimated heart disease risks in HIV patients
— ZA 43104 — Better access to HIV screening with self-test kits at selected pharmacies
— ZA 43110 — Anti-AIDS program in peril after US finds nurses in Mozambique provided abortions
— ZA 43116 — Mike Snow: infectious diseases specialist who treated the UK's first HIV patients
— ZA 43115 — The case for PEPFAR to push for country ownership in HIV response
— ZA 43114 — Summarizing SGLT-2 Inhibitor Usage in People With Diabetes and HIV
— ZA 43111 — Gilead and US government settle to resolve HIV patent dispute
— ZA 43109 — Effect of antiretroviral therapy on the mortality of HIV-1 infection long-term non-progressors
— ZA 43113 — Cancer therapy and vaccine maker GeoVax gains on progress in cancer drug trials
— ZA 43112 — Infectious Disease Expert Jennifer Jao to Help Lead AIDS Clinical-Trials Network
— ZA 43120 — Baguio workers urged to undergo HIV testing
— ZA 43117 — Nurse with HIV and her dad speak out as new HSE awareness campaign says sex is ...
— ZA 43118 — The translational landscape of HIV-1 infected cells reveals key gene regulatory principles
— ZA 43119 — MedMira Receives Health Canada Approval for Point-of-Care HIV Test
— ZA 43124 — 'It's not a death sentence anymore,' says Cork woman living with HIV
— ZA 43123 — Let's change the game for people living with HIV
— ZA 43121 — Kenya's Health Crisis: Critical medicine and supply shortages hit hospitals
— ZA 43122 — HSE campaign to highlight advances in HIV treatment
— ZA 43128 — Supreme Court will weigh reinstating Obamacare care requirements
— ZA 43131 — Gilead's new HIV prevention drug lenacapavir will 'change the face of HIV,' says CEO Daniel O'Day
— ZA 43132 — AI Chatbot Deployed To Target Drug Resistance
— ZA 43129 — Recent Incarceration and HIV Risk Among Women Who Use Heroin
— ZA 43126 — HIV-diagnosed cases in major markets projected to hit 2.2 million by 2033
— ZA 43125 — Queer, HIV-Positive, and Running Out of Medication in Gaza
— ZA 43130 — Supreme Court to weigh HIV prevention coverage mandate
— ZA 43127 — The impact of extreme weather events on HIV prevention and care
— ZA 43137 — Promoting positive masculinity to end gender-based violence in Armenia
— ZA 43140 — Nigeria's Women Bear the Burden of HIV
— ZA 43138 — St. Michael's research leads to Health Canada approval of dual HIV-Syphilis rapid test
— ZA 43136 — HIV drug access crisis persists despite trial success
— ZA 43135 — HIV Trends in Metropolitan US Cities From 2014 to 2021: Baseline Data for the Ending
— ZA 43134 — NGO implements project to reduce HIV/TB stigma, discrimination in UWR
— ZA 43133 — The next frontier in the fight against HIV
— ZA 43139 — The hMPV virus may be spreading in China – why it's not cause for alarm
— ZA 43141 — Harm reduction saves lives
— ZA 43142 — The association between rapid antiretroviral therapy initiation and brain structure and ...
— ZA 43143 — Innovative HIV Testing Expanded in Liverpool
— ZA 43144 — AI technology supports global efforts against antimicrobial resistance
— ZA 43146 — Thyroid Abnormalities Possible in Patients Living With HIV
— ZA 43147 — High frequency CCR5 editing in human hematopoietic stem progenitor cells protects ...
— ZA 43148 — HIV Self-Test Now Approved for Use in Adolescents
— ZA 43145 — Bacterial STIs and Doxycycline Postexposure Prophylaxis Among Individuals Using HIV PrEP
— ZA 43155 — A randomized trial of the impact of a text-messaging program on HIV incidence and STI ...
— ZA 43156 — HIV stigma is now more dangerous than the virus – my research shows how to address this
— ZA 43154 — Brunei introduces HIV introduction programme as part of schools awareness initiatives
— ZA 43153 — Feasibility and staff acceptability of implementing Xpert HIV-1 viral load point-of-care testing
— ZA 43152 — WHO announces the development of new guidelines for lenacapavir and updated HIV ...
— ZA 43151 — The Vivienne's tragic last social media post days before devastating death
— ZA 43150 — HIV drug lenacapavir is a breakthrough in treating AIDS
— ZA 43149 — People Living With HIV Satisfied With Telemedicine During Pandemic
— ZA 43158 — This HIV drug is hailed as 2024's Discovery of the Year
— ZA 43159 — Minnesota summer camp for HIV-positive children closing
— ZA 43157 — Phoenix puts out call to artists for HIV/AIDS mural at downtown health center
— ZA 43164 — Delhi High Court orders treatment for HIV positive transwoman with no identity proof
— ZA 43160 — Vaccines can put an end to HIV – African governments must take the lead in developing them
— ZA 43161 — HIV care | Lenacapavir was the breakthrough drug in 2024
— ZA 43162 — Top 5 Most-Read HIV Articles of 2024
— ZA 43163 — HIV and cancer treatment: the biggest medical advances of 2024